EUVIMEDOpdag EUVIMED
Übersichtsarbeit

On‐Demand Activatable PROTACs for Targeted Protein Degradation

Caiyun Guo, Zhibin Ren, Xiaomei Wu, Qingxin Yao iD, Yuan Gao iD

Chemistry – A European Journal · 2026

DOI: 10.1002/chem.71283 ↗

At a glance

Übersichtsarbeit in Chemistry – A European Journal, 2026. Written by Caiyun Guo and 4 co-authors. Institution: State Key Laboratory of Chemical Resource Engineering, MOE Key Lab of Biomedical Materials of Natural Macromolecules, Beijing University of Chemical …. Major MEDLINE topics: Ubiquitin-Protein Ligases, Prodrugs. 112 references. Funded by: National Natural Science Foundation of China, Beijing Natural Science Foundation, Open Funding Project of the State Key Laboratory of Biopharmaceutical Preparation and Delivery.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Targeted protein degradation (TPD) has emerged as a transformative paradigm in the biomedical research. Central to this field are Proteolysis‐targeting chimeras (PROTACs), bifunctional molecules exhibiting immense therapeutic potential, particularly in oncology and autoimmune diseases. By recruiting target proteins to E3 ubiquitin ligases, PROTACs harness the ubiquitin‐proteasome system (UPS) to induce protein degradation. This event‐driven mechanism overcomes the “target occupancy‐driven” limitations of conventional small‐molecule inhibitors, offering novel avenues for tackling undruggable targets. Despite this promise, conventional PROTACs face significant translational challenges, including poor tissue specificity, off‐target toxicity, and insufficient accumulation within the tumor microenvironment. Therefore, the development of on‐demand activatable PROTAC prodrugs, capable of spatiotemporally precise protein degradation, has become a central research focus in this field. This review systematically summarizes the design principles and research progress of three major categories of activatable PROTACs: endogenously activatable PROTACs, exogenously photo‐activatable PROTACs, and bioorthogonally activatable PROTACs. We also compare the merits and limitations of these strategies to foster a deeper understanding of the field and accelerate the clinical advancement of PROTAC‐based therapeutics.

Subjects

MeSH terms (MEDLINE)

Ubiquitin-Protein LigasesProdrugsHumansProteolysisProteolysis Targeting ChimeraProteasome Endopeptidase ComplexUbiquitinAnimals

Author keywords

PROTACsactivationcancerprodrugtargeted protein degradation

Substances

Proteolysis Targeting ChimeraUbiquitin-Protein LigasesProdrugsProteasome Endopeptidase ComplexUbiquitin

Authors and institutions

  • State Key Laboratory of Chemical Resource Engineering, MOE Key Lab of Biomedical Materials of Natural Macromolecules, Beijing University of Chemical Technology, Beijing, China.

ORCID profiles: Qingxin Yao, Yuan Gao

Funding

  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation
  • Open Funding Project of the State Key Laboratory of Biopharmaceutical Preparation and Delivery
  • Fundamental Research Funds for the Central Universities
  • Natural Science Foundation of Beijing Municipality

Cite

APA

Guo, C., Ren, Z., Wu, X., Yao, Q., & Gao, Y. (2026). On‐Demand Activatable PROTACs for Targeted Protein Degradation. Chemistry – A European Journal. https://doi.org/10.1002/chem.71283

Vancouver

Guo C, Ren Z, Wu X, Yao Q, Gao Y. On‐Demand Activatable PROTACs for Targeted Protein Degradation. Chemistry – A European Journal. 2026. doi:10.1002/chem.71283

BibTeX
@article{Guo2026,
  author = {Guo, Caiyun and Ren, Zhibin and Wu, Xiaomei and Yao, Qingxin and Gao, Yuan},
  title = {On‐Demand Activatable PROTACs for Targeted Protein Degradation},
  journal = {Chemistry – A European Journal},
  year = {2026},
  doi = {10.1002/chem.71283}
}
Start for free →